Literature DB >> 15710386

IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.

Seung-Hoon Lee1, Jung-Whan Kim, Sun-Hee Oh, Yong-Jin Kim, Seung-Bae Rho, Kyungsook Park, Kui-Lea Park, Je-Ho Lee.   

Abstract

Telomerase activation is regulated by the expression of human telomerase reverse transcriptase (hTERT) and is a key step in the development of human cancers. Interferon-gamma (IFN-gamma) signaling induces growth arrest in many tumors through multiple regulatory mechanisms. The p27 tumor suppressor protein inhibits the formation of tumors through the induction of cell cycle arrest and/or apoptosis. We demonstrate here that p27Kip1 inhibits hTERT mRNA expression and telomerase activity through post-transcriptional up-regulation by IFN-gamma/IRF-1 signaling. The ectopic expression of p27 suppressed hTERT expression and telomerase activity in human cervical cancer cell lines, HeLa and HT3. Furthermore, hTERT promoter activity of mouse embryonic fibroblasts (MEFs) deficient in p27 (p27-/- MEFs) was significantly higher than that of wild-type MEFs. Overexpression of p27 suppressed hTERT promoter activity and telomerase activity of p27-/- MEFs. In addition p27 down-regulated E7 protein expression and in transiently transfected HeLa cells, E7 increased hTERT promoter activity. In conclusion, we propose that inhibition of the hTERT expression and telomerase activity may be a novel tumor suppressor function of p27.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710386     DOI: 10.1016/j.febslet.2005.01.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.

Authors:  Fang Li; Jinquan Cui
Journal:  Med Oncol       Date:  2015-06-12       Impact factor: 3.064

2.  Green tea compound in chemoprevention of cervical cancer.

Authors:  Changping Zou; Huaguang Liu; Jean M Feugang; Zhengping Hao; H-H Sherry Chow; Francisco Garcia
Journal:  Int J Gynecol Cancer       Date:  2010-05       Impact factor: 3.437

3.  Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.

Authors:  Joseph George; Naren L Banik; Swapan K Ray
Journal:  Int J Biochem Cell Biol       Date:  2010-04-13       Impact factor: 5.085

4.  Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells.

Authors:  Mrinmay Chakrabarti; Naren L Banik; Swapan K Ray
Journal:  J Mol Neurosci       Date:  2013-02-17       Impact factor: 3.444

5.  Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-γ.

Authors:  Daniel C Tanner; Jonathan D Cherry; Margot Mayer-Pröschel
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

6.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

7.  Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma.

Authors:  Joseph George; Naren L Banik; Swapan K Ray
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

8.  Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

9.  3-O-methylfunicone, a metabolite of Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G(2) + M arrest and inducing apoptosis.

Authors:  A Baroni; A De Luca; A De Filippis; M Petrazzuolo; L Manente; R Nicoletti; M A Tufano; E Buommino
Journal:  Cell Prolif       Date:  2009-05-22       Impact factor: 6.831

Review 10.  Telomerase as a useful target in cancer fighting-the breast cancer case.

Authors:  Hanna Holysz; Natalia Lipinska; Anna Paszel-Jaworska; Blazej Rubis
Journal:  Tumour Biol       Date:  2013-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.